Paclitaxel-Coated versus Uncoated Balloon for Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis
Background: Several prospective controlled trials to date have assessed the safety and efficacy of paclitaxel-coated balloon angioplasty (PCBA) versus uncoated balloon angioplasty (UCBA) for femoropopliteal (FP) in-stent restenosis (ISR). Therefore, this meta-analysis of prospective controlled trial...
Main Authors: | Qiwei Li, Li Wang, Lu Zhu, Yong Wu, Limin Wu, Hanmin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
IMR Press
2022-09-01
|
Series: | Reviews in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.imrpress.com/journal/RCM/23/9/10.31083/j.rcm2309315 |
Similar Items
-
Evaluation of Femoropopliteal In-Stent Restenosis Characteristics Stratified by Stent Design
by: Elias Noory, et al.
Published: (2023-11-01) -
Debulking plus drug-coated balloon angioplasty versus
drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions
by: Liqiang Li, et al.
Published: (2022-09-01) -
Assessment of Mortality and Factors Affecting Outcome of Use of Paclitaxel-Coated Stents and Bare Metal Stents in Femoropopliteal PAD
by: Aleksander Falkowski, et al.
Published: (2020-07-01) -
Long coverage with drug-eluting stents is superior to spot coverage for long femoropopliteal artery disease: PARADE II study
by: Jong-Il Park, et al.
Published: (2022-10-01) -
Long-term outcome and factors associated with restenosis after combination therapy of balloon angioplasty and stenting for symptomatic intracranial stenosis
by: Toshihiro Ueda, et al.
Published: (2022-12-01)